130 related articles for article (PubMed ID: 8565268)
1. Serum levels of soluble CD30 in chronic hepatitis B virus infection.
Fattovich G; Vinante F; Giustina G; Morosato L; Alberti A; Ruol A; Pizzolo G
Clin Exp Immunol; 1996 Jan; 103(1):105-10. PubMed ID: 8565268
[TBL] [Abstract][Full Text] [Related]
2. Concentrations of cytokines, soluble interleukin-2 receptor, and soluble CD30 in sera of patients with hepatitis B virus infection during acute and convalescent phases.
Monsalve-De Castillo F; Romero TA; Estévez J; Costa LL; Atencio R; Porto L; Callejas D
Clin Diagn Lab Immunol; 2002 Nov; 9(6):1372-5. PubMed ID: 12414777
[TBL] [Abstract][Full Text] [Related]
3. [Serum levels of soluble CD30 molecule in hepatitis B virus infection].
Monsalve F; Romero-A T; Estévez J; Costa L; Callejas D
Rev Med Chil; 2001 Nov; 129(11):1248-52. PubMed ID: 11836876
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum levels of soluble CD30 in patients with atopic dermatitis (AD).
Bengtsson A; Holm L; Bäck O; Fransson J; Scheynius A
Clin Exp Immunol; 1997 Sep; 109(3):533-7. PubMed ID: 9328133
[TBL] [Abstract][Full Text] [Related]
5. Maternal serum soluble CD30 is increased in pregnancies complicated with acute pyelonephritis.
Kusanovic JP; Romero R; Esoinoza J; Gotsch F; Edwin S; Chaiworapongsa T; Mittal P; Soto E; Erez O; Mazaki-Tovi S; Than NG; Friel LA; Yoon BH; Mazor M; Hassan SS
J Matern Fetal Neonatal Med; 2007 Nov; 20(11):803-11. PubMed ID: 17853184
[TBL] [Abstract][Full Text] [Related]
6. Circulating soluble-CD30 (sCD30) in patients with HCV-related chronic hepatitis and in patients with alcoholic liver disease.
De Lazzari F; Ravagnan P; Tenderini M; Vicarioto MA; Galliani EA; Lorenzoni U; Popovic A; Floreani A
Hepatogastroenterology; 2002; 49(43):231-4. PubMed ID: 11941962
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection.
Böcher WO; Herzog-Hauff S; Herr W; Heermann K; Gerken G; Meyer Zum Büschenfelde KH; Löhr HF
Clin Exp Immunol; 1996 Jul; 105(1):52-8. PubMed ID: 8697635
[TBL] [Abstract][Full Text] [Related]
8. Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies.
Kusanovic JP; Romero R; Hassan SS; Gotsch F; Edwin S; Chaiworapongsa T; Erez O; Mittal P; Mazaki-Tovi S; Soto E; Than NG; Friel LA; Yoon BH; Espinoza J
J Matern Fetal Neonatal Med; 2007 Dec; 20(12):867-78. PubMed ID: 17853188
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum and CSF levels of soluble CD30 during clinical remission in multiple sclerosis.
McMillan SA; McDonnell GV; Douglas JP; Droogan AG; Hawkins SA
Neurology; 1998 Oct; 51(4):1156-60. PubMed ID: 9781547
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of soluble interleukin-2 receptors in acute and chronic viral hepatitis.
Alberti A; Chemello L; Fattovich G; Pontisso P; Semenzato G; Colletta C; Vinante F; Pizzolo G
Dig Dis Sci; 1989 Oct; 34(10):1559-63. PubMed ID: 2507263
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of soluble Tac peptide in acute and chronic hepatitis B virus infection.
Chu CM; Liaw YF
Clin Immunol Immunopathol; 1989 Oct; 53(1):52-8. PubMed ID: 2788545
[TBL] [Abstract][Full Text] [Related]
12. High plasma levels of the soluble form of CD30 activation molecule reflect disease activity in patients with Wegener's granulomatosis.
Wang G; Hansen H; Tatsis E; Csernok E; Lemke H; Gross WL
Am J Med; 1997 Jun; 102(6):517-23. PubMed ID: 9217665
[TBL] [Abstract][Full Text] [Related]
13. T-helper 2 involvement in the pathogenesis of bullous pemphigoid: role of soluble CD30 (sCD30).
De Pitá O; Frezzolini A; Cianchini G; Ruffelli M; Teofoli P; Puddu P
Arch Dermatol Res; 1997 Nov; 289(12):667-70. PubMed ID: 9452886
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis with isolated serum antibody to hepatitis B core antigen. A variant of non-A, non-B hepatitis?
Lai KN; Lai FM; Leung NW; Lo ST; Tam JS
Am J Clin Pathol; 1990 Jan; 93(1):79-83. PubMed ID: 2104740
[TBL] [Abstract][Full Text] [Related]
15. Ratios of T-helper 2 Cells to T-helper 1 Cells and Cytokine Levels in Patients with Hepatitis B.
Li MH; Zhang D; Zhang L; Qu XJ; Lu Y; Shen G; Wu SL; Chang M; Liu RY; Hu LP; Hao HX; Hua WH; Song SJ; Wan G; Liu SA; Xie Y
Chin Med J (Engl); 2017 Aug; 130(15):1810-1815. PubMed ID: 28748854
[TBL] [Abstract][Full Text] [Related]
16. Changes in serum hepatitis B virus (HBV) DNA positivity in chronic HBV infection: results of a long-term follow-up study of 138 patients.
Alberti A; Pontisso P; Fattovich G; Schiavon E; Chemello L; Bortolotti F; Tremolada F; Realdi G
J Infect Dis; 1986 Oct; 154(4):562-9. PubMed ID: 3745970
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of soluble CD30 are increased in children with chronic renal failure and with primary growth deficiency and decrease during treatment with recombination human growth hormone.
Barbano G; Cappa F; Prigione I; Pistoia V; Cohen A; Chiesa S; Gusmano R; Perfumo F
Nephrol Dial Transplant; 2001 Sep; 16(9):1807-13. PubMed ID: 11522862
[TBL] [Abstract][Full Text] [Related]
18. High serum level of soluble CD30 in acute primary HIV-1 infection.
Pizzolo G; Vinante F; Nadali G; Krampera M; Morosato L; Chilosi M; Raiteri R; Sinicco A
Clin Exp Immunol; 1997 May; 108(2):251-3. PubMed ID: 9158093
[TBL] [Abstract][Full Text] [Related]
19. Soluble cytokine receptor CD30 in atopic disorders: a case-control study.
Latza U; Davis S; Wilhelm D; McKnight B; Seyfarth M; Stein H
Clin Exp Allergy; 1999 Jan; 29(1):97-104. PubMed ID: 10051708
[TBL] [Abstract][Full Text] [Related]
20. [Liver pathological changes and clinical features of patients with chronic hepatitis B virus infection in their immune tolerant phase and non-active status].
Li J; Zhao GM; Zhu LM; Li Y; Xin SJ
Zhonghua Gan Zang Bing Za Zhi; 2007 May; 15(5):326-9. PubMed ID: 17524261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
